ArtusLabs

PE's most recent catch, the latest in a string of recent informatics purchases, markets the Nexxis electronic laboratory notebook; Nexxis iLAB, a laboratory automation platform; and LimsLink, a lab integration software platform.

"We see informatics as a real opportunity," PerkinElmer CEO Robert Friel said during a conference call to discuss the company's Q1 results. Now the company is mulling how to integrate the three new software firms it acquired over the past two months.

PerkinElmer has completed its acquisition of ArtusLabs and has agreed to purchase CambridgeSoft. The combined purchase price for the two software firms totals $220 million.

The two deals for $220 million in aggregate will expand PerkinElmer's informatics and software offerings and enable customers to access and share enterprise-wide data "for faster, more informed scientific decisions."

News Scan

Premium

DiscoveryBioMed, ArtusLabs, Heptares Therapeutics, Gentronix, GlaxoSmithKline, BioFocus DPI, Eli Lilly, Millipore, Epitome, ChanTest, Applied Cell Sciences, BioTime, Embryome Sciences, Reproductive Genetics Institute of Chicago, Arizona State University Biodesign Institute, VisionGate

The partnership will use ArtusLabs' web-based platform Ensemble for Life Science as the data-management platform.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.